Both in Pharmaceuticals
Ovid Therapeutics vs Neurogene
Over the past year OVID returned +45.3% and NGNE returned −19.9%; their daily moves had a correlation of 0.23.
OVID +45.3% NGNE −19.9%Growth of $1, one year, split-adjusted
| Metric | OVID | NGNE |
|---|---|---|
| Price | $2.15 | $23.25 |
| Market cap | $419.9M | $465.3M |
| Today | −4.87% | −2.92% |
| 1 month | −20.4% | −28.3% |
| 6 months | −26.1% | −16.5% |
| Year to date | +31.9% | +12.9% |
| 1 year | +30.3% | −32.4% |
| Revenue growth (YoY) | −88.3% | — |
| Gross margin | 100.0% | — |
| Net margin | −2047.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 265.2× | — |
| Net cash | $117.2M | $225.4M |
| Dividend yield | — | — |
| Volatility (60d) | 53.1% | 63.1% |
| Short % of float | 12.0% | 38.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).